sever
acut
respiratori
syndrom
sar
new
infecti
diseas
first
emerg
guangdong
provinc
china
novemb
novel
coronaviru
later
identifi
patient
sar
detect
viru
patient
absenc
healthi
control
patient
atyp
pneumonia
reproduct
similar
diseas
relev
anim
model
fulfil
koch
postul
implic
coronaviru
causal
agent
sar
full
genom
sequenc
determin
within
week
viru
identif
rapid
progress
aetiolog
develop
laboratori
diagnost
test
defin
rout
viral
transmiss
facilit
uniqu
whocoordin
virtual
network
laboratori
share
inform
realtim
basi
daili
teleconfer
subsequ
studi
indic
sar
coronaviru
anim
origin
precursor
still
present
anim
popul
within
region
liveanim
market
southern
china
may
provid
animalhuman
interphas
allow
precursor
viru
adapt
humanhuman
transmiss
find
underscor
potenti
reemerg
sar
need
laboratori
test
earli
diagnosi
howev
low
viral
load
respiratori
tract
make
earli
diagnosi
sar
diagnost
challeng
although
improv
sensit
molecular
diagnost
method
continu
made
sever
acut
respiratori
syndrom
sar
new
infecti
respiratori
diseas
typic
associ
fever
short
breath
cough
pneumonia
emerg
southern
china
late
within
month
diseas
spread
global
affect
patient
countri
fatal
half
infect
directli
trace
one
index
patient
arriv
hong
kong
feb
acquir
diseas
guangdong
dramat
illustr
impact
modern
air
travel
spread
emerg
human
infect
outbreak
brought
control
concert
global
effort
coordin
juli
humanhuman
transmiss
take
place
global
outbreak
declar
mani
way
unpreced
global
experi
rapid
extent
spread
magnitud
impact
health
system
economi
effect
control
first
known
case
unusu
diseas
occur
foshan
guangdong
provinc
china
novemb
similar
case
subsequ
report
heyuan
affect
famili
member
healthcar
worker
contact
index
case
chef
work
exot
game
restaur
shenzhen
mani
earli
patient
epidemiolog
link
liveanim
market
trade
januari
diseas
spread
guangzhou
capit
guangdong
provinc
caus
major
outbreak
primarili
affect
healthcar
worker
end
januari
characterist
diseas
recognis
rapidli
progress
atyp
pneumonia
without
leucocytosi
refractori
convent
antibiot
therapi
associ
outbreak
famili
hospit
set
clinician
guangzhou
term
infecti
atyp
pneumonia
sever
causal
agent
consider
time
includ
chlamydia
found
necropsi
tissu
patient
die
diseas
howev
clinic
progress
lack
respons
appropri
macrolid
antibiot
argu
role
chlamydia
diseas
meanwhil
outbreak
diseas
guangzhou
caus
concern
even
panic
among
resid
report
local
region
media
feb
inform
case
guangdong
provinc
healthcar
worker
five
report
death
health
author
hong
kong
set
enhanc
epidemiolog
microbiolog
surveil
case
atyp
pneumonia
especi
histori
recent
travel
mainland
china
although
sever
causal
agent
identifi
patient
atyp
pneumonia
diagnos
hong
kong
first
agent
note
avian
influenza
subtyp
famili
return
fujian
earli
februari
find
rais
concern
avian
influenza
viru
may
respons
outbreak
guangdong
global
pandem
alert
declar
prepar
vaccin
develop
start
howev
investig
reveal
case
avian
influenza
patient
guangdong
hong
kong
end
februari
cluster
pneumon
ill
healthcar
worker
report
hospit
hanoi
associ
index
patient
recent
travel
hong
kong
march
similar
outbreak
ill
healthcar
worker
report
princ
wale
hospit
hong
kong
provid
preliminari
case
definit
name
sever
acut
respiratori
syndrom
diseas
time
addit
suspect
case
report
toronto
singapor
issu
global
alert
subsequ
travel
advisori
warn
unnecessari
travel
affect
region
identif
causal
agent
clearli
prioriti
effort
contain
spread
novel
diseas
march
initi
virtual
network
laboratori
investig
caus
sar
daili
teleconfer
updat
member
network
progress
laboratori
investig
differ
part
world
patient
suspect
sar
investig
establish
influenza
common
respiratori
pathogen
caus
novel
diseas
syndrom
strategi
detect
novel
agent
includ
use
direct
electron
microscopi
respiratori
specimen
bronchoalveolar
lavag
lung
tissu
obtain
lung
biopsi
necropsi
cultur
cell
line
known
support
respiratori
viral
infect
subsequ
type
cell
pcr
reversetranscript
pcr
rtpcr
consensu
primer
respiratori
viral
pathogen
randomprim
rtpcr
method
serolog
use
detect
agent
antigen
relat
known
respiratori
pathogen
one
problem
face
investig
differenti
sar
routin
caus
atyp
pneumonia
one
featur
support
probabl
diagnosi
sar
epidemiolog
linkag
cluster
similar
diseas
case
substanti
number
case
initi
present
guangzhou
hospit
outbreak
hanoi
princ
wale
hospit
hong
kong
subsequ
toronto
singapor
global
case
notif
suspect
case
singapor
also
intercept
flight
arriv
frankfurt
germani
member
network
report
viruslik
particl
clinic
respiratori
specimen
electron
microscopi
viru
particl
pleomorph
morpholog
compat
paramyxovirus
shortli
human
metapneumoviru
detect
respiratori
tract
patient
sar
princ
wale
hospit
hong
kong
toronto
howev
human
metapneumoviru
consist
detect
patient
sar
hong
kong
outsid
princ
wale
hospit
elsewher
global
addit
genet
sequenc
human
metapneumoviru
isol
patient
essenti
similar
previous
known
circul
human
be
difficult
explain
human
metapneumoviru
known
human
pathogen
mani
year
would
caus
novel
unusu
diseas
syndrom
sar
rhinoviru
chlamydia
also
detect
patient
suspect
sar
three
laboratori
within
network
independ
report
isol
novel
coronaviru
clinic
specimen
patient
sar
three
laboratori
strategi
led
detect
novel
coronaviru
broadli
similar
although
cultur
cell
line
includ
mdck
hela
rde
usual
use
cultur
respiratori
virus
prove
unproduct
viru
isol
cell
two
laboratori
cell
even
natur
viru
identifi
link
sar
establish
show
serum
sampl
patient
suspect
sar
increas
antibodi
titr
virusinfect
cell
indirect
immunofluoresc
assay
iifa
identif
agent
coronaviru
made
use
thinsect
electron
microscopi
virusinfect
cell
neg
stain
prepar
cellcultur
supernat
viru
infect
figur
independ
confirm
ident
viru
obtain
sequenc
fragment
viral
genom
deriv
randomprim
rtpcr
two
laboratori
use
consensu
primer
coronavirus
laboratori
three
laboratori
region
yield
earli
sequenc
inform
open
read
frame
orf
region
replicas
gene
possibl
highli
conserv
region
viru
dna
array
analysi
use
microarray
contain
probe
variou
viru
famili
done
infect
uninfect
cell
analysi
gave
posit
signal
group
eight
oligonucleotid
whose
sequenc
deriv
two
viru
famili
coronavirida
astrovirida
howev
microarray
analysi
could
done
viru
isol
cultur
could
done
directli
clinic
specimen
independ
detect
three
laboratori
coronaviruslik
agent
sampl
patient
sarslik
diseas
hong
kong
vietnam
singapor
germani
patient
singapor
led
particular
credenc
signific
observ
howev
conclus
establish
causal
role
novel
coronaviru
viru
consist
found
relev
clinic
specimen
patient
diseas
healthi
control
rtpcr
method
base
initi
genet
sequenc
viru
replicas
gene
design
appli
detect
viral
rna
patient
specimen
viru
isol
also
use
iifa
eia
detect
serolog
respons
acut
convalesc
serum
specimen
approach
infect
novel
coronaviru
subsequ
name
sarsassoci
coronaviru
detect
consecut
patient
clinic
suspect
sar
hong
kong
patient
pair
serum
sampl
avail
seroconvert
posit
sar
coronaviru
viral
rna
detect
rtpcr
healthi
control
serum
sampl
healthi
blood
donor
hong
kong
even
though
outbreak
sar
time
antibodi
reactiv
cell
infect
sar
coronaviru
iifa
second
studi
found
evid
sar
coronaviru
rtpcr
viru
cultur
patient
sar
vietnam
hong
kong
singapor
nine
patient
serum
sampl
avail
increas
antibodi
titr
viru
furthermor
randomli
select
serum
sampl
us
blood
donor
reactiv
sar
coronaviru
eia
third
studi
found
five
patient
probabl
sar
three
patient
suspect
sar
origin
singapor
vietnam
evid
sar
coronaviru
rna
rtpcr
taken
togeth
result
indic
novel
coronaviru
associ
sar
given
lack
serolog
reactiv
human
be
suggest
probabl
recent
introduc
human
popul
basi
partial
genet
inform
avail
viru
seem
agent
previous
known
circul
human
popul
like
origin
viru
anim
sourc
fulfil
koch
postul
establish
caus
diseas
requir
microb
detect
site
diseas
sar
coronaviru
detect
lung
biopsi
bronchoalveolar
lavag
patient
sar
viru
cultur
rtpcr
electron
microscopi
addit
viruslik
particl
compat
size
morpholog
coronaviru
shown
lung
biopsi
tissu
bronchoalveolar
lavag
lung
patholog
fatal
sar
show
bronchial
epitheli
denud
loss
cilia
type
pneumocyt
hyperplasia
patient
die
later
cours
diseas
syncyti
cell
seen
alveoli
sar
coronaviru
rna
shown
lung
rtpcr
insitu
hybridis
viral
antigen
detect
alveolar
epitheli
cell
macrophag
immunohistolog
unpublish
data
evid
human
metapneumoviru
detect
lung
rtpcr
electron
microscopi
serolog
respons
pair
serum
sampl
final
requir
fulfil
koch
postul
establish
caus
infecti
diseas
reproduct
diseas
relev
anim
model
infect
cynomolg
macaqu
isol
sar
coronaviru
led
diseas
patholog
similar
seen
human
patient
sar
epitheli
necrosi
serosanguin
alveolar
exud
hyalin
membran
type
pneumocyt
hyperplasia
presenc
syncytia
viru
success
reisol
lesion
antibodi
respons
viru
shown
infect
anim
contrast
infect
macaqu
human
metapneumoviru
produc
mild
suppur
rhiniti
minim
eros
infect
airway
possibl
remain
coinfect
human
metapneumoviru
could
exacerb
diseas
caus
sar
coronaviru
howev
evid
human
metapneumoviru
infect
rtpcr
serolog
method
patient
sever
fatal
sar
sar
coronaviru
detect
patient
suggest
human
metapneumoviru
necessari
develop
sever
fatal
sar
addit
infect
macaqu
sar
coronaviru
follow
human
metapneumoviru
produc
enhanc
diseas
thu
conclud
sar
coronaviru
necessari
suffici
caus
full
syndrom
sar
subsequ
shown
sar
coronaviru
infect
replic
cat
ferret
transmit
uninfect
anim
recent
sar
coronaviru
also
shown
infect
replic
mice
although
without
overt
diseas
experi
provid
altern
anim
model
investig
sar
macaqu
ferret
model
show
clinic
signific
diseas
within
week
isol
novel
coronaviru
associ
sar
full
genom
viru
sequenc
analysi
genom
sar
coronaviru
confirm
complet
novel
across
whole
length
deriv
recombin
previous
known
anim
human
coronavirus
find
also
confirm
sar
coronaviru
could
artifici
gener
laboratori
bioterrorist
agent
coronavirus
envelop
virus
singl
positivestrand
rna
genom
coronavirus
five
major
orf
encod
replicas
spike
envelop
membran
nucleocapsid
protein
virus
subdivid
three
group
basi
antigen
genet
studi
previous
known
human
coronavirus
classifi
group
eg
group
eg
sar
coronaviru
show
serolog
crossreact
antisera
rais
human
review
sar
aetiolog
origin
diagnosi
coronaviru
group
partial
initi
viral
sequenc
viral
replicas
indic
sar
coronaviru
genet
distinct
previous
known
coronavirus
characteris
full
genom
confirm
deduct
suggest
viru
distantli
relat
coronavirus
group
find
prompt
conclus
either
sar
coronaviru
repres
new
fourth
group
within
coronaviru
genu
repres
group
viru
diverg
other
group
earli
evolut
howev
unlik
group
virus
sar
coronaviru
contain
haemagglutininesteras
protein
encod
sequenc
work
requir
confirm
taxonom
classif
viru
avail
full
genet
sequenc
allow
refin
diagnost
assay
see
ration
antivir
drug
design
vaccin
develop
origin
molecular
epidemiolog
sar
recent
introduct
novel
coronaviru
human
be
without
prior
serolog
evid
infect
human
popul
prompt
much
specul
origin
viru
wherea
bioengin
even
extraterrestri
agent
adduc
explain
origin
probabl
explan
anim
viru
recent
acquir
abil
humanhuman
transmiss
hypothesi
strengthen
report
earli
patient
sar
guangdong
expos
live
wild
game
anim
held
market
serv
restaur
trade
freshli
cook
game
meat
search
anim
sourc
precursor
viru
prompt
figur
sampl
sever
anim
speci
found
one
livegam
market
guangdong
reveal
carri
viru
genet
antigen
relat
human
sar
coronaviru
particular
sarslik
coronaviru
detect
rtpcr
nasal
faecal
swab
civet
cat
paguma
larvata
raccoon
dog
nyctereut
procyonoid
serolog
evid
infect
found
speci
also
chines
ferretbadg
melogal
moschata
genet
sequenc
viru
reveal
anim
coronaviru
homolog
human
sar
coronaviru
figur
howev
compar
anim
virus
human
sar
coronaviru
seem
delet
figur
addit
sequenc
predict
anim
viru
express
put
protein
aminoacid
seen
human
sar
coronaviru
interestingli
subsequ
studi
reveal
genotyp
similar
delet
orf
studi
virus
delet
isol
earli
phase
epidem
addit
virus
delet
result
loss
whole
region
found
may
ie
late
phase
outbreak
result
ap
indic
express
dispens
sar
coronaviru
human
be
altern
also
tempt
specul
delet
might
give
viru
advantag
adapt
human
be
anim
trader
work
live
anim
market
high
seropreval
human
anim
sar
coronaviru
although
histori
sarslik
diseas
anim
precursor
sar
coronaviru
thu
like
ineffici
infect
human
be
repeat
exposur
precursor
anim
viru
probabl
lead
abort
infect
antigen
stimul
result
observ
serolog
respons
anim
handler
find
taken
histori
exposur
liveanim
market
provid
earli
patient
sar
suggest
liveanim
market
probabl
site
interspeci
transfer
anim
viru
human
be
occur
seem
viru
introduc
liveanim
market
divers
fauna
small
mammal
precursor
sar
coronaviru
effici
establish
sever
small
mammalian
speci
studi
avian
influenza
virus
livepoultri
market
shown
virus
amplifi
within
set
market
trade
live
bird
like
precursor
sar
coronaviru
likewis
market
divers
mammalian
speci
anim
remov
ad
ecosystem
regular
basi
howev
reservoir
viru
natur
remain
conclus
identifi
palm
civet
raccoon
dog
current
candid
equal
anoth
speci
could
reservoir
viru
wild
civet
cat
similar
speci
serv
amplifi
diseas
set
liveanim
market
work
requir
identifi
natur
reservoir
viru
detail
molecular
epidemiolog
investig
indic
virus
detect
human
be
earli
stage
sar
outbreak
guangdong
close
relat
anim
sar
coronaviru
virus
addit
sequenc
seen
anim
virus
earli
virus
found
genet
divers
prone
mutat
virus
isol
later
cours
outbreak
suggest
sar
coronaviru
process
host
adapt
subject
high
select
pressur
earli
phase
outbreak
isol
causal
agent
determin
partial
genom
sequenc
provid
basi
first
gener
laboratori
test
sar
rtpcr
test
base
sequenc
sar
coronaviru
replicas
gene
first
part
genom
sequenc
serolog
test
base
iifa
virusinfect
cell
eia
base
viral
cell
extract
viru
isol
sensit
labour
intens
took
long
clinic
relev
although
test
use
combin
prove
robust
use
retrospect
diagnosi
sar
prove
less
satisfactori
provid
diagnosi
first
day
diseas
onset
first
gener
rtpcr
assay
sensit
end
first
week
ill
specimen
test
posit
first
day
diseas
howev
assay
provid
import
insight
pathogenesi
transmiss
diseas
viru
detect
rtpcr
cultur
respiratori
tract
also
faec
urin
replic
viru
gastrointestin
tract
confirm
electron
microscop
studi
biopsi
upper
lower
intestin
mucosa
patient
sar
find
suggest
infect
sar
coronaviru
dissemin
simpli
confin
respiratori
tract
also
rais
possibl
infect
could
spread
faecal
rout
rout
prove
import
least
one
major
commun
outbreak
amoy
garden
hong
kong
patient
infect
within
period
day
presum
contamin
faec
quantit
rtpcr
assay
nasopharyng
aspir
well
rate
posit
firstgener
rtpcr
assay
differ
stage
ill
show
unlik
respiratori
viral
infect
viral
load
rate
posit
sar
coronaviru
upper
respiratori
tract
increas
progress
peak
around
day
diseas
onset
find
provid
reason
rtpcr
assay
poor
sensit
earli
cours
diseas
also
predict
viru
transmiss
would
lower
first
day
ill
find
support
epidemiolog
observ
wherea
viral
rna
could
detect
rtpcr
mani
week
even
month
onset
diseas
viru
cultur
possibl
first
week
ill
possibl
even
though
viru
replic
continu
first
week
diseas
viru
may
complex
antibodi
therefor
longer
infect
transmiss
find
also
agreement
epidemiolog
find
apart
respiratori
sampl
viral
rna
also
detect
stool
blood
cerebrospin
fluid
urin
nonrespiratori
sampl
stool
specimen
highest
proport
posit
rtpcr
result
one
studi
stool
sampl
collect
later
ill
mean
day
posit
convent
rtpcr
assay
observ
agre
report
stool
sampl
might
good
altern
respiratori
sampl
identif
sar
patient
howev
one
studi
indic
viral
rna
detect
stool
sampl
within
first
day
ill
suggest
stool
sampl
might
use
earli
diagnosi
sar
low
sensit
convent
rtpcr
assay
first
day
diseas
period
laboratori
diagnosi
relev
patient
care
prompt
explor
sever
strategi
improv
test
sensit
quantit
realtim
rtpcr
approach
use
improv
sensit
well
turnaround
time
method
benefit
close
system
reduc
chanc
pcr
crosscontamin
within
laboratori
importantli
technolog
combin
autom
specimen
extract
method
potenti
becom
high
throughput
assay
signific
advantag
area
outbreak
sar
larg
number
specimen
test
addit
assay
provid
quantit
viral
load
data
help
elucid
pathogenesi
diseas
exampl
assay
show
viral
load
highest
specimen
lower
respiratori
tract
eg
bronchoalveolar
lavag
sputum
endotrach
aspir
higher
nasopharyng
aspir
throat
swab
faecal
sampl
high
viral
load
toward
end
first
week
ill
specimen
choic
second
week
diseas
approach
also
use
enhanc
detect
rate
sar
sensit
detect
could
increas
test
multipl
serial
sampl
collect
patient
howev
increas
alreadi
high
workload
clinic
diagnost
laboratori
realtim
nest
rtpcr
strategi
shown
use
detect
low
copi
number
sar
coronaviru
present
earli
stage
ill
turnaround
time
method
much
shorter
convent
nest
rtpcr
assay
howev
nest
rtpcr
increas
risk
laboratori
crosscontamin
lead
falseposit
result
infect
cell
coronavirus
gener
subgenom
mrna
synthesi
structur
viral
protein
discontinu
transcript
genom
organis
sar
coronaviru
subgenom
mrna
molecul
contain
nucleocapsid
gene
sequenc
region
sar
coronaviru
thu
target
nucleocapsid
gene
sequenc
expect
enhanc
sensit
diagnosi
prove
case
appli
specimen
collect
experiment
infect
macaqu
howev
sever
independ
studi
clinic
specimen
patient
sar
prove
otherwis
show
viral
rna
clinic
specimen
genom
origin
howev
review
sar
aetiolog
origin
diagnosi
advis
rtpcr
assay
target
differ
part
viral
genom
serv
confirm
posit
result
strategi
provid
assur
posit
result
due
laboratori
contamin
pcr
amplicon
given
analyt
sensit
rtpcr
assay
could
increas
much
option
enhanc
test
sensit
increas
amount
viral
rna
ad
rtpcr
reaction
mix
extract
rna
sampl
larger
volum
nasopharyng
aspir
appli
quantit
realtim
rtpcr
technolog
sensit
sarscoronaviru
detect
improv
approxim
nasopharyng
aspir
specimen
collect
day
diseas
onset
specif
method
necessarili
associ
increas
pcr
inhibitor
howev
strategi
impli
inhibitor
control
import
assur
falseneg
result
due
pcr
inhibit
initi
studi
serum
plasma
thought
use
molecular
diagnosi
sar
howev
subsequ
studi
plasma
serum
sampl
sar
patient
show
sar
coronaviru
rna
detect
plasma
serum
sampl
first
week
ill
anoth
studi
use
multipl
serial
plasma
sampl
sar
patient
within
first
day
ill
could
identifi
quantit
rtpcr
recent
studi
show
sar
coronaviru
rna
detect
claim
replic
peripher
blood
mononuclear
cell
sar
patient
earli
diseas
whether
viral
rna
origin
infect
peripher
blood
mononuclear
cell
phagocytosi
endocytosi
viru
replic
respiratori
tract
still
unclear
nevertheless
blood
leucocyt
may
provid
yet
anoth
altern
earli
sar
diagnosi
howev
sar
coronaviru
viraemia
occur
mainli
within
first
week
diseas
addit
outsid
period
sar
epidem
respiratori
infect
caus
pathogen
respiratori
specimen
still
remain
import
clinic
specimen
clinic
investig
accord
result
firstgener
rtpcr
assay
patient
posit
rtpcr
result
admiss
wors
outcom
term
surviv
requir
intens
care
assist
ventil
compar
sar
patient
neg
rtpcr
result
admiss
find
presum
surrog
viral
load
earli
diseas
recent
hypothesi
confirm
use
quantit
rtpcr
high
viral
load
nasopharyng
aspir
found
independ
predictor
mortal
viral
load
patient
die
diseas
recent
shown
log
higher
patient
eventu
recov
ill
high
viral
load
also
associ
occurr
diarrhoea
requir
intens
care
thu
quantit
pcr
assay
might
provid
critic
prognost
inform
clinic
manag
particular
viral
load
major
predictor
clinic
outcom
effect
antivir
therapi
help
reduc
viral
load
like
provid
clinic
benefit
serodiagnosi
current
gold
standard
confirm
diagnosi
sar
iifa
use
virusinfect
cell
spot
onto
teflonco
microwel
slide
eia
base
extract
virusinfect
cell
coat
microwel
eia
plate
prove
reliabl
method
diagnosi
sar
howev
seroconvers
usual
occur
week
ill
patient
seroconvert
late
day
diseas
onset
thu
serolog
option
earli
diagnosi
diseas
detect
igm
iga
subclassspecif
antibodi
allow
earlier
diagnosi
test
requir
cultur
live
sar
coronaviru
provid
relev
antigen
use
assay
requir
reliabl
inactiv
viru
infect
use
outsid
biohazard
level
contain
recombin
viral
nucleoprotein
spike
protein
antigen
express
escherichia
coli
substrat
assess
altern
serolog
test
platform
potenti
provid
low
cost
reproduc
nonhazard
serolog
test
eia
format
amen
high
throughput
test
howev
born
mind
antigen
assay
format
must
individu
test
assess
possibl
crossreact
relat
human
coronavirus
wherea
serolog
crossreact
prove
major
problem
whole
nativ
viral
antigen
assay
mention
assum
mean
recombin
antigen
equal
specif
shown
furthermor
although
serolog
crossreact
prove
problem
period
sar
outbreak
postsar
era
prior
probabl
sar
extrem
low
posit
serolog
result
must
treat
even
greater
caution
addit
two
known
human
coronavirus
new
human
coronaviru
discov
possibl
crossreact
human
coronavirus
although
rare
real
must
taken
serious
furthermor
individu
vari
antigen
epitop
produc
antibodi
henc
crossreact
may
well
rare
event
although
result
interpret
care
may
major
implic
public
health
therefor
suggest
posit
serolog
result
confirm
neutralis
test
refer
laboratori
period
outbreak
sar
clinic
specimen
investig
sar
test
particular
care
posit
rtpcr
result
confirm
independ
molecular
test
differ
specimen
rtpcr
test
differ
genom
target
eg
replicas
gene
nucleoprotein
gene
avail
refer
laboratori
confirm
posit
result
select
use
confirm
neg
result
patient
high
degre
suspicion
serial
specimen
mani
site
eg
respiratori
faec
serum
test
addit
avoid
obtain
falseneg
result
assay
intern
pcr
inhibitor
control
encourag
posit
result
confirm
independ
refer
laboratori
serolog
assay
show
signific
rise
antibodi
titr
nativ
viral
antigen
eg
iifa
confirm
viru
neutralis
human
infect
anim
sarslik
coronaviru
like
encount
may
behav
atyp
compar
sar
exampl
clinic
diseas
may
milder
viral
load
may
even
lower
transient
sar
mean
even
greater
vigil
may
requir
make
diagnosi
infect
sarsrel
anim
coronaviru
possibl
option
reemerg
sar
includ
undetect
continu
transmiss
viru
outbreak
summer
escap
viru
laboratori
contain
live
sar
coronaviru
reemerg
viru
anim
reservoir
present
evid
viru
persist
human
popul
although
viru
may
detect
rtpcr
faec
month
onset
diseas
viru
isol
rare
possibl
third
week
ill
evid
diseas
transmiss
patient
late
convalesc
possibl
immunocompromis
patient
aid
may
harbour
viru
long
term
consid
howev
epidemiolog
relev
transmiss
case
occur
sar
manifest
given
intens
global
surveil
awar
exist
escap
viru
laboratori
inde
occur
three
occas
highlight
import
biosafeti
provid
strict
biohazard
guidelin
handl
viru
secur
storag
least
one
event
involv
handl
viru
thought
chemic
inactiv
thu
research
use
appropri
intern
accept
method
inactiv
live
virus
detail
studi
sarscoronaviru
inactiv
recent
report
prevent
inadvert
laboratoryacquir
infect
lead
secondari
transmiss
commun
happen
laboratori
infect
beij
high
level
alert
febril
respiratori
ill
laboratori
worker
handl
infecti
sar
coronaviru
need
maintain
reemerg
viru
anim
reservoir
remain
possibl
given
viru
detect
faec
respiratori
secret
small
mammal
within
liveanim
market
southern
china
reemerg
four
patient
sar
guangdong
decemb
januari
epidemiolog
genet
linkag
livegam
market
virus
isol
prompt
wholesal
cull
civet
cat
small
mammal
market
januari
human
case
sar
acquir
anim
sinc
detect
